BACKGROUND: The mortality burden of the 2009 A/H1N1 influenza pandemic remains controversial, in part because of delays in reporting of vital statistics that are traditionally used to measure influenza-related excess mortality. Here, we compare excess mortality rates and years of life lost (YLL) for pandemic and seasonal influenza in Mexico and evaluate laboratory-confirmed death reports. METHODS: Monthly age- and cause-specific death rates from January 2000 through April 2010 and population-based surveillance of influenza virus activity were used to estimate excess mortality and YLL in Mexico. Age-stratified laboratory-confirmed A/H1N1 death reports were obtained from an active surveillance system covering 40% of the population. RESULTS: The A/H1N1 pandemic was associated with 11.1 excess all-cause deaths per 100,000 population and 445,000 YLL during the 3 waves of virus activity in Mexico, April-December 2009. The pandemic mortality burden was 0.6-2.6 times that of a typical influenza season and lower than that of the severe 2003-2004 influenza epidemic. Individuals aged 5-19 and 20-59 years were disproportionately affected relative to their experience with seasonal influenza. Laboratory-confirmed deaths captured 1 of 7 pandemic excess deaths overall but only 1 of 41 deaths in persons >60 years of age in 2009. A recrudescence of excess mortality was observed in older persons during winter 2010, in a period when influenza and respiratory syncytial virus cocirculated. CONCLUSIONS: Mexico experienced higher 2009 A/H1N1 pandemic mortality burden than other countries for which estimates are available. Further analyses of detailed vital statistics are required to assess geographical variation in the mortality patterns of this pandemic.
BACKGROUND: The mortality burden of the 2009 A/H1N1influenza pandemic remains controversial, in part because of delays in reporting of vital statistics that are traditionally used to measure influenza-related excess mortality. Here, we compare excess mortality rates and years of life lost (YLL) for pandemic and seasonal influenza in Mexico and evaluate laboratory-confirmed death reports. METHODS: Monthly age- and cause-specific death rates from January 2000 through April 2010 and population-based surveillance of influenza virus activity were used to estimate excess mortality and YLL in Mexico. Age-stratified laboratory-confirmed A/H1N1 death reports were obtained from an active surveillance system covering 40% of the population. RESULTS: The A/H1N1 pandemic was associated with 11.1 excess all-cause deaths per 100,000 population and 445,000 YLL during the 3 waves of virus activity in Mexico, April-December 2009. The pandemic mortality burden was 0.6-2.6 times that of a typical influenza season and lower than that of the severe 2003-2004 influenza epidemic. Individuals aged 5-19 and 20-59 years were disproportionately affected relative to their experience with seasonal influenza. Laboratory-confirmed deaths captured 1 of 7 pandemic excess deaths overall but only 1 of 41 deaths in persons >60 years of age in 2009. A recrudescence of excess mortality was observed in older persons during winter 2010, in a period when influenza and respiratory syncytial virus cocirculated. CONCLUSIONS: Mexico experienced higher 2009 A/H1N1 pandemic mortality burden than other countries for which estimates are available. Further analyses of detailed vital statistics are required to assess geographical variation in the mortality patterns of this pandemic.
Authors: Santiago Echevarría-Zuno; Juan Manuel Mejía-Aranguré; Alvaro J Mar-Obeso; Concepción Grajales-Muñiz; Eduardo Robles-Pérez; Margot González-León; Manuel Carlos Ortega-Alvarez; Cesar Gonzalez-Bonilla; Ramón Alberto Rascón-Pacheco; Víctor Hugo Borja-Aburto Journal: Lancet Date: 2009-11-11 Impact factor: 79.321
Authors: Liam J Donaldson; Paul D Rutter; Benjamin M Ellis; Felix E C Greaves; Oliver T Mytton; Richard G Pebody; Iain E Yardley Journal: BMJ Date: 2009-12-10
Authors: Carrie Reed; Frederick J Angulo; David L Swerdlow; Marc Lipsitch; Martin I Meltzer; Daniel Jernigan; Lyn Finelli Journal: Emerg Infect Dis Date: 2009-12 Impact factor: 6.883
Authors: Maria de Fatima Marinho de Souza; Marc-Alain Widdowson; Airlane P Alencar; Vilma P Gawryszewski; Eduardo Aziz-Baumgartner; Rakhee Palekar; Joseph Breese; Po-Yung Cheng; Jarbas Barbosa; Ana M Cabrera; Andrea Olea; Arturo B Flores; David K Shay; Anthony Mounts; Otavio P Oliva Journal: Bull World Health Organ Date: 2013-05-31 Impact factor: 9.408
Authors: Ying Zhou; Eric H Y Lau; Dennis K M Ip; Hiroshi Nishiura; Gabriel M Leung; Wing-Hong Seto; Benjamin J Cowling Journal: Am J Epidemiol Date: 2013-08-26 Impact factor: 4.897
Authors: Jack N Salto-Quintana; Gerardo Rivera-Alfaro; Evelyn L Sánchez-Ramos; Alejandro Gómez-Gómez; Daniel E Noyola Journal: Pathog Glob Health Date: 2019-03-21 Impact factor: 2.894
Authors: Li Li; Jessica Y Wong; Peng Wu; Helen S Bond; Eric H Y Lau; Sheena G Sullivan; Benjamin J Cowling Journal: Am J Epidemiol Date: 2018-02-01 Impact factor: 4.897
Authors: Javier Dávila-Torres; Gerardo Chowell; Víctor H Borja-Aburto; Cécile Viboud; Concepción Grajalez-Muñiz; Mark A Miller Journal: Arch Med Res Date: 2014-11-20 Impact factor: 2.235
Authors: Jessica Y Wong; Peng Wu; Hiroshi Nishiura; Edward Goldstein; Eric H Y Lau; Lin Yang; S K Chuang; Thomas Tsang; J S Malik Peiris; Joseph T Wu; Benjamin J Cowling Journal: Am J Epidemiol Date: 2013-03-03 Impact factor: 4.897
Authors: Víctor H Borja-Aburto; Gerardo Chowell; Cécile Viboud; Lone Simonsen; Mark A Miller; Concepción Grajales-Muñiz; Cesar R González-Bonilla; Jose A Diaz-Quiñonez; Santiago Echevarría-Zuno Journal: Arch Med Res Date: 2012-10-16 Impact factor: 2.235